Bicara Therapeutics Inc. appoints Jeremy Bender and Christy Oliger to board of directors

Bicara Therapeutics Inc. appoints Jeremy Bender and Christy Oliger to board of directors
Bicara adds new board members

Bicara Therapeutics Inc. has named Jeremy Bender, Ph.D., MBA, and Christy Oliger to its Board of Directors, strengthening its leadership with more than 50 years of combined biopharma experience.

The company stated that the new appointments will help guide its strategy and execution as it enters a new phase of growth. Bender and Oliger are recognized as established leaders in the biopharmaceutical sector. The full announcement can be found on Bicara Therapeutics Inc.'s website.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.